(Q44395842)

2 December 2017

title

Relationship between beta-amyloid degradation and the 26S proteasome in neural cells (English)

1 reference

2 December 2017

M Lopez Salon

1 reference

2 December 2017

L Pasquini

1 reference

2 December 2017

M Besio Moreno

1 reference

2 December 2017

J M Pasquini

1 reference

2 December 2017

E Soto

1 reference

2 December 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

2 December 2017

published in

Experimental Neurology

1 reference

2 December 2017

volume

180

1 reference

2 December 2017

1 reference

2 December 2017

page(s)

131-143

1 reference

Effect of oxidant systems on the ubiquitylation of proteins in the central nervous system

2 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Impairment of the ubiquitin-proteasome system by protein aggregation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Methodological variables in the assessment of beta amyloid neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Central glial and neuronal populations display differential sensitivity to ceramide-dependent cell death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

The ubiquitin-proteasome pathway: the complexity and myriad functions of proteins death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Mutant ubiquitin expressed in Alzheimer's disease causes neuronal death.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Proteasome inhibition in oxidative stress neurotoxicity: implications for heat shock proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Bcl-2 acts subsequent to and independent of Ca2+ fluxes to inhibit apoptosis in thapsigargin- and glucocorticoid-treated mouse lymphoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Lactacystin, proteasome function, and cell fate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Pathological lesions of Alzheimer's disease and dementia with Lewy bodies brains exhibit immunoreactivity to an ATPase that is a regulatory subunit of the 26S proteasome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Amyloidosis of the nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Ubiquitin-mediated degradative pathway degrades the extracellular but not the intracellular form of amyloid beta-protein precursor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Amyloid β-Protein Inhibits Ubiquitin-dependent Protein Degradation in Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Amyloid protein and neurofibrillary tangles coexist in the same neuron in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Amyloid of neurofibrillary tangles of Guamanian parkinsonism-dementia and Alzheimer disease share identical amino acid sequence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Amyloid beta-peptide is produced by cultured cells during normal metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Genetic classification of primary neurodegenerative disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

α 2 -macroglobulin associates with β-amyloid peptide and prevents fibril formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

APPSW Transgenic Mice Develop Age-related Aβ Deposits and Neuropil Abnormalities, but no Neuronal Loss in CA1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Impaired proteasome function in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Intracellular amyloid-beta 1-42, but not extracellular soluble amyloid-beta peptides, induces neuronal apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Inhibition of the ubiquitin-proteasome system in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Amyloid precursor protein metabolism in primary cell cultures of neurons, astrocytes, and microglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Defective ubiquitination of cerebral proteins in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Ubiquitin carboxyl-terminal hydrolase (PGP 9.5) is selectively present in ubiquitinated inclusion bodies characteristic of human neurodegenerative diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Oxidative stress hypothesis in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Proteolytic Degradation of Alzheimer's Disease Amyloid β‐Peptide by a Metalloproteinase from Microglia Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

beta-Amyloid peptide produced in vitro is degraded by proteinases released by cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Lactacystin, a specific inhibitor of the proteasome, induces apoptosis and activates caspase-3 in cultured cerebellar granule cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Immunochemical Properties of Ubiquitin Conjugates in the Paired Helical Filaments of Alzheimer Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

beta-Amyloid induces neuritic dystrophy in vitro: similarities with Alzheimer pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Proteasome inhibitors induce cytochrome c-caspase-3-like protease-mediated apoptosis in cultured cortical neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Degradation of amyloid beta-protein by a metalloprotease secreted by microglia and other neural and non-neural cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Production of the Alzheimer amyloid beta protein by normal proteolytic processing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Topographical relationship between beta-amyloid and tau protein epitopes in tangle-bearing cells in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Cerebral soluble ubiquitin is increased in patients with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Brain ubiquitin is markedly elevated in Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-4886%2802%2900060-2

10.1016/S0014-4886(02)00060-2

7 January 2021

Identifiers

DOI

1 reference

2 December 2017

1 reference